Efficiency of SARS-CoV-2 vaccines in breast cancer patients: single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)

Background: Cancer patients are more sensitive to infection induced by SARS-CoV-2, especially ones with impaired immune response. Vaccines are approved as safe and effective, and they are recommended in oncology patients. The aim of our study was to see the percentage of reinfections after second dose of vaccines against SARS-CoV2.